Special Leave Sought to Appeal Gene Sequencing Decision to the High Court of Australia
We recently reported on the decision by a five judge bench of the Full Court of the Federal Court of Australia (Full Court) which found that Myriad Genetics Inc’s patent covering the isolated BRCA1 gene is valid. The Full Court unanimously rejected an appeal by Ms. Yvonne D’Arcy from a decision by Justice Nicholas at first instance. Read our alert here.
It is now being reported that Ms. D’Arcy has sought special leave to appeal the decision to the High Court of Australia (High Court).